Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2025 Earnings Call Transcript February 24, 2026
Vaxcyte, Inc. misses on earnings expectations. Reported EPS is $-1.8 EPS, expectations were $-1.46.
Operator: Good afternoon. My name is Chloe, and I will be your conference operator for the Vaxcyte Fourth Quarter and Full Year 2025 Financial Results Conference Call. [Operator Instructions] Today’s call is being recorded. I will now turn the call over to Andrew Guggenhime, President and Chief Financial Officer of...
